£80.64

It has never been this cheap. We have no record of a lower price.

£81 today · cheaper than every other day in the last 3 months

Springer Brain Metastases: 136 (Cancer Treatment and Research, 136)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£80.64 £76.61 £78.22 £79.83 £81.45 £83.06 £84.67 25 July 2026 06 August 2026 18 August 2026 30 August 2026 11 September 2026
View at Amazon ↗

Price data last checked 42 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 49 days • 1 price levels

Days at Price
49 days 0 12 25 37 49 £81 Days at Price

Price Analysis

Most common price: £81 (49 days, 100.0%)

Price range: £81 - £81

Price levels: 1 different prices over 49 days

Description

Brain metastases are the most dreaded complication of systemic cancer, affecting approximately 170,000 people a year, a far greater incidence than primary brain tumors. Advances in modern chemotherapy have led to an improved control of system cancers, often with agents that poorly penetrate the central nervous system, resulting in an increasing incidence of brain metastases. Traditional chemotherapy has had little impact on brain metastases. The main therapeutic option is radiation therapy, and in a small number of patients - surgery. However, refinements in all of these treatments offer some positive outcomes and an increased ability to stratify patients based on certain criteria. This book will bring current information on the presentation and management of patients with brain metastases, providing available data, giving guidelines that can be applied in day to day practice, updated information for neuro-surgeons, radiation oncologists, medical oncologists, and neuro-oncologists, as well as an overview for physicians in training.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
25 November 2014
Listed Since
14 December 2014

Barcode

No barcode data available

Similar Products You Might Like

Brain Cancer Therapy and Surgical Interventions (Horizons in Cancer Research)
97% match

Brain Cancer Therapy and Surgical Interventions (Horizons in Cancer Research)

£114.14 19 Sep 2026
Metastases to the Central Nervous System, An Issue of Neurosurgery Clinics of North America: Volume 31-4 (The Clinics: Surgery, Volume 31-4)
97% match

Metastases to the Central Nervous System, An Issue of Neurosurgery Clinics of North America: Volume 31-4 (The Clinics: Surgery, Volume 31-4)

Elsevier

£87.70 24 Sep 2026
Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 1
97% match

Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 1

Elsevier

£117.95 01 Oct 2026
Elsevier Neuro-Oncology for the Clinical Neurologist Book
97% match

Elsevier Neuro-Oncology for the Clinical Neurologist Book

Elsevier

£78.29 22 Aug 2026
Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)
96% match

Tumors of the Central Nervous system, Volume 3: Brain Tumors (Part 1)

Springer

£149.00 02 Oct 2026
Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)
96% match

Late Effects of Treatment for Brain Tumors: 150 (Cancer Treatment and Research, 150)

Springer

£120.59 17 Sep 2026
Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy
96% match

Molecular Markers of Brain Tumor Cells: Implications for Diagnosis, Prognosis and Anti-Neoplastic Biological Therapy

Springer

£113.09 26 Sep 2026
Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)
96% match

Primary Central Nervous System Tumors: Pathogenesis and Therapy (Current Clinical Oncology)

Humana

£155.47 27 Sep 2026
Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)
96% match

Tumors of the Central Nervous System, Volume 4: Brain Tumors (Part 2)

Springer

£147.49 24 Sep 2026
Stereotactic Radiosurgery for the Treatment of Central Nervous System Meningiomas
96% match

Stereotactic Radiosurgery for the Treatment of Central Nervous System Meningiomas

Springer

£61.84 02 Oct 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
96% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£213.71 02 Sep 2026
Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)
96% match

Biology of Brain Tumour: Proceedings of the Second International Symposium on Biology of Brain Tumour (London, October 24–26, 1984)

Springer

£247.78 02 Sep 2026
Central Nervous System Metastases
96% match

Central Nervous System Metastases

Springer

£89.28 22 Sep 2026
Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 2
96% match

Brain Metastases from Primary Tumors: Epidemiology, Biology, and Therapy: 2

Elsevier

£91.26 18 Sep 2026
Evidence based practice in Neuro-oncology
96% match

Evidence based practice in Neuro-oncology

Springer

£81.74 17 Sep 2026
Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)
96% match

Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies (Volume 15) (Cancer Sensitizing Agents for Chemotherapy, Volume 15)

Elsevier

£119.00 23 Sep 2026